Suzhou, China

Tingting Hu

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Smartnuclide Biopharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tingting Hu. Retrieved from https://idiyas.com/inventor/tingting-hu-y8o9egh5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tingting Hu: Innovator in Biomedicine

Introduction

Tingting Hu is a prominent inventor based in Suzhou, China. She has made significant contributions to the field of biomedicine, particularly in the development of innovative polypeptides.

Latest Patents

Tingting Hu holds a patent for a PD-L1-binding polypeptide and its applications. This invention is crucial for detecting and diagnosing PD-L1 related diseases, including various forms of cancer. Her work in this area showcases her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Tingting Hu is associated with Suzhou Smartnuclide Biopharmaceutical Co., Ltd. Her role in this company allows her to leverage her expertise in biomedicine to drive research and development efforts.

Collaborations

She collaborates with notable colleagues, including Tao Xu and Yan Sun, who contribute to her innovative projects and research initiatives.

Conclusion

Tingting Hu's work in biomedicine, particularly her patent on PD-L1-binding polypeptides, highlights her role as a key innovator in the field. Her contributions are paving the way for advancements in cancer detection and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…